Control of death receptor and mitochondrial-dependent apoptosis by c-Jun N-terminal kinase in hippocampal CA1 neurones following global transient ischaemia

被引:58
作者
Carboni, S
Antonsson, B
Gaillard, P
Gotteland, JP
Gillon, JY
Vitte, PA
机构
[1] Serono Pharmaceut Res Inst, Dept Pharmacol, CH-1228 Geneva, Switzerland
[2] Serono Pharmaceut Res Inst, Dept Prot Biochem, CH-1228 Geneva, Switzerland
[3] Serono Pharmaceut Res Inst, Dept Chem, CH-1228 Geneva, Switzerland
关键词
apoptosis; caspase; c-Jun N-terminal kinase; global ischaemia; neuroprotection;
D O I
10.1111/j.1471-4159.2004.02925.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
c-Jun N-terminal kinase (JNK), a member of the mitogen-activated protein kinase family, is activated in response to a number of extracellular stimuli, including inflammatory cytokines, UV irradiation and ischaemia. A large body of evidence supports a role for JNK signalling in stress-induced apoptosis. It has been hypothesized that JNK may contribute to the apoptotic response by regulating the intrinsic cell death pathway involving the mitochondria. Here, we examined the role of the JNK signalling pathway in hippocampal CA1 apoptotic neurones following transient ischaemia in gerbils. We showed early activation of death receptor-dependent apoptosis (caspase-8 activation 2 days after ischaemia) and a biphasic activation of caspase-3 and caspase-9 after ischaemia. Activation of the mitochondrial pathway, as measured by cytochrome c release, appeared as a late event (5-7 days after ischaemia). AS601245, a novel JNK inhibitor, antagonized activation of both pathways and significantly protected CA1 neurones from cell death. Our results suggest a key role of JNK in the control of death receptor and mitochondrial-dependent apoptosis after transient ischaemia.
引用
收藏
页码:1054 / 1060
页数:7
相关论文
共 31 条
[1]  
[Anonymous], 1974, STEREOTAXIC ATLAS MO, DOI DOI 10.1007/s00429-016-1259-0
[2]   Translocation of cytochrome c following transient global ischemia in the gerbil [J].
Antonawich, FJ .
NEUROSCIENCE LETTERS, 1999, 274 (02) :123-126
[3]   Biochemical pathways of caspase activation during apoptosis [J].
Budihardjo, I ;
Oliver, H ;
Lutter, M ;
Luo, X ;
Wang, XD .
ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY, 1999, 15 :269-290
[4]   AS601245 (1,3-benzothiazol-2-yl(2-{[2-(3-pyridinyl)ethyl]amino}-4 pyrimidinyl) acetonitrile):: A c-Jun NH2-terminal protein kinase inhibitor with neuroprotective properties [J].
Carboni, S ;
Hiver, A ;
Szyndralewiez, C ;
Gaillard, P ;
Gotteland, JP ;
Vitte, PA .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2004, 310 (01) :25-32
[5]  
Chen J, 1996, J NEUROCHEM, V67, P64
[6]   Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition [J].
Du, CY ;
Fang, M ;
Li, YC ;
Li, L ;
Wang, XD .
CELL, 2000, 102 (01) :33-42
[7]   Attenuation of delayed neuronal death after mild focal ischemia in mice by inhibition of the caspase family [J].
Endres, H ;
Namura, S ;
Skimizu-Sasamata, M ;
Waeber, C ;
Zhang, L ;
Gómez-Isla, T ;
Hyman, BT ;
Moskowitz, MA .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 1998, 18 (03) :238-247
[8]   Inhibition of c-Jun N-terminal kinase decreases cardiomyocyte apoptosis and infarct size after myocardial ischemia and reperfusion in anaesthetized rats [J].
Ferrandi, C ;
Ballerio, R ;
Gaillard, P ;
Giachetti, C ;
Carboni, S ;
Vitte, PA ;
Gotteland, JP ;
Cirillo, R .
BRITISH JOURNAL OF PHARMACOLOGY, 2004, 142 (06) :953-960
[9]   IDENTIFICATION OF PROGRAMMED CELL-DEATH INSITU VIA SPECIFIC LABELING OF NUCLEAR-DNA FRAGMENTATION [J].
GAVRIELI, Y ;
SHERMAN, Y ;
BENSASSON, SA .
JOURNAL OF CELL BIOLOGY, 1992, 119 (03) :493-501
[10]   Expression of cell death-associated phospho-c-Jun and p53-activated gene 608 in hippocampal CA1 neurons following global ischemia [J].
Gillardon, F ;
Spranger, M ;
Tiesler, C ;
Hossmann, KA .
MOLECULAR BRAIN RESEARCH, 1999, 73 (1-2) :138-143